Events

Part 4 of our Healthcare Ethics: Community, Value, & Leadership Series

Precision medicine holds great promise for improving the prevention, diagnosis and treatment of many diseases.

Advances in precision medicine have already led to powerful new discoveries and several new treatments that are tailored to specific characteristics, such as a person’s genetic makeup, or the genetic profile of an individual’s tumor. As the number of effective targeted therapies grows, more patients are being assessed for genetic variations; indeed, some experts believe that sequencing a patient’s genome will soon be standard procedure. But there are many challenges being faced including enormous costs of treatment, regulatory, infrastructure, logistical, and ethical issues. This panel will explore the promise and perils of precision medicine. 

Participants will earn 1.5 hours of ACHE Face-to-Face Education Credit.

Moderator

• Maria Rosario (Marichi) C. Capino, MPH, MSN, RN, CPHQ - Risk Management and Patient Safety, Risk Management Consultant

Panelists

• Akunna Iheanacho, PhD - Chief Scientific Officer, Texcell-North America, Inc.
• Kevin Bliden, MBA - Director of Clinical Trials, Thrombosis Research and Drug Development, LifeBridge Health

2 Step registration process required

• Our virtual event will utilize the ACHE Learning Management System (LMS );  ACHE LMS will record attendance, conduct evaluations, and automatically report any earned F2F CEUs to your profile.
• Attendees must fully participate (90 minutes) in the live chapter event to receive all 1.5 ACHE Face-to-Face Education credits.
• Once you complete the StarChapter event registration, you will receive a link to register for the event on the ACHE website.  Please note registration on the ACHE website is required to recieve the zoom link to gain access to the live event.